| 000 | 01845 a2200541 4500 | ||
|---|---|---|---|
| 005 | 20250516195450.0 | ||
| 264 | 0 | _c20150213 | |
| 008 | 201502s 0 0 eng d | ||
| 022 | _a1573-4978 | ||
| 024 | 7 |
_a10.1007/s11033-014-3231-5 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aOztuzcu, Serdar | |
| 245 | 0 | 0 |
_aEvaluation of Factor V G1691A, prothrombin G20210A, Factor XIII V34L, MTHFR A1298C, MTHFR C677T and PAI-1 4G/5G genotype frequencies of patients subjected to cardiovascular disease (CVD) panel in south-east region of Turkey. _h[electronic resource] |
| 260 |
_bMolecular biology reports _cJun 2014 |
||
| 300 |
_a3671-6 p. _bdigital |
||
| 500 | _aPublication Type: Evaluation Study; Journal Article | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aCardiovascular Diseases _xgenetics |
| 650 | 0 | 4 | _aChild |
| 650 | 0 | 4 | _aChild, Preschool |
| 650 | 0 | 4 | _aDNA Mutational Analysis |
| 650 | 0 | 4 |
_aFactor V _xgenetics |
| 650 | 0 | 4 |
_aFactor XIII _xgenetics |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aGenetic Predisposition to Disease |
| 650 | 0 | 4 | _aGenotype |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInfant |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMethylenetetrahydrofolate Reductase (NADPH2) _xgenetics |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aPlasminogen Activator Inhibitor 1 _xgenetics |
| 650 | 0 | 4 |
_aProthrombin _xgenetics |
| 650 | 0 | 4 | _aTurkey |
| 700 | 1 | _aErgun, Sercan | |
| 700 | 1 | _aUlaşlı, Mustafa | |
| 700 | 1 | _aNacarkahya, Gülper | |
| 700 | 1 | _aIğci, Yusuf Ziya | |
| 700 | 1 | _aIğci, Mehri | |
| 700 | 1 | _aBayraktar, Recep | |
| 700 | 1 | _aTamer, Ali | |
| 700 | 1 | _aÇakmak, Ecir Ali | |
| 700 | 1 | _aArslan, Ahmet | |
| 773 | 0 |
_tMolecular biology reports _gvol. 41 _gno. 6 _gp. 3671-6 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/s11033-014-3231-5 _zAvailable from publisher's website |
| 999 |
_c23550004 _d23550004 |
||